2009 – Pulmonary Hypertension and Pulmonary Vascular Biology

This exceptional two-day conference provided a forum for clinicians on the frontlines of treating patients with pulmonary vascular disease and researchers interested in advancing our understanding of pulmonary vascular biology.

Clinical Applications

The agenda for the first day focused on clinical updates in pulmonary diseases, including an emphasis on Pulmonary Hypertension. The program was an excellent opportunity for physicians interested in learning about the latest developments in pulmonary medicine, and specifically in pulmonary hypertension.

The morning sessions of the first day covered updates in broad areas of pulmonary disease, presented by national leaders in pulmonary medicine. The distinguished speakers included:

The afternoon of day one featured a clinical spotlight on Pulmonary Hypertension Diagnosis and Management, presented by national leaders in Pulmonary Hypertension, including:

Following all speaker sessions, a poster reception was held for researchers to present original research. The day concluded with an evening banquet featuring Lewis J. Rubin, MD from the University of California, San Diego, who discussed the future of multi-drug therapy for pulmonary hypertension.

Research Developments

The second day of the conference focused on translational research in pulmonary vascular disease presented by leaders in the field, including:

Scientific Sessions:

  • Clinical Masters: Update on Obstructive Lung Disease
  • Clinical Masters: Update on ILD, PE, Sleep Apnea and ARDS
  • Clinical Spot Light on: Pulmonary Hypertension
  • Pulmonary Hypertension: Novel Small Molecule Therapeutics
  • New Mechanisms of Pulmonary Vascular Disease
  • Dysregulation of Nitric Oxide, Reactive Oxygen Species, and Hydrogen Sulfide in Pulmonary Hypertension Vasculopathy
  • Genetics, Structure and Function in Pulmonary Hypertension